help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, N.
Right arrow Articles by Sundaram, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, N.
Right arrow Articles by Sundaram, K.

Endocrinology, Vol 136, 4887-4893, Copyright © 1995 by Endocrine Society


ARTICLES

Mechanism of androgen-induced thymolysis in rats

N Kumar, LX Shan, MP Hardy, CW Bardin and K Sundaram
Center for Biomedical Research, Population Council, New York, New York 10021, USA.

To investigate the mechanism of androgen-induced thymolysis, the effects of various androgens, including testosterone (T), 19- nortestosterone, and 7 alpha-methyl-19-nortestosterone (MENT), were compared with those of estradiol and dexamethasone (DEX) in intact, castrated, and adrenalectomized male rats. The potency comparisons on thymus regression, based on mass of steroids, showed DEX to be the most potent, followed by estradiol and the androgens. Among the androgens, MENT was the most potent, followed by nortestosterone and T, an order similar to their anabolic potency on muscle. As the thymolytic effects of T and MENT were not altered by the concomitant administration of an aromatase inhibitor or a 5-reductase inhibitor, it was concluded that the effects of androgens were not mediated by their conversion to estrogens or 5 alpha-reduced metabolites. Involvement of glucocorticoid receptors in androgen action was excluded because mifepristone (an antiglucocorticoid) blocked DEX-induced, but not T- or MENT-induced, thymus regression. Flutamide, an antiandrogen, significantly blocked the thymolytic effect of T and MENT, providing further support for this conclusion. This suggested that the thymolytic action of androgens is an intrinsic property mediated via androgen receptors (AR). The occurrence of AR in the thymus was demonstrated by binding assays and the presence of AR messenger RNA (mRNA) by reverse transcriptase- polymerase chain reaction. Quantitative reverse transcriptase- polymerase chain reaction for AR mRNA in the thymus showed 6-fold more AR mRNA in the thymic epithelial cells than in the thymocytes. However, epithelial cells represent only a small fraction of the thymus. Hence, it is hypothesized that the androgens produce their thymolytic effects by stimulating the secretion of a factor(s) by the thymic epithelial cells that, in turn, causes regression of the thymus.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Mucci, E. Mocetti, M. S. Leguizamon, and O. Campetella
A Sexual Dimorphism in Intrathymic Sialylation Survey Is Revealed by the trans-Sialidase from Trypanosoma cruzi
J. Immunol., April 15, 2005; 174(8): 4545 - 4550.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Shetty, G. Wilson, M. P. Hardy, E. Niu, I. Huhtaniemi, and M. L. Meistrich
Inhibition of Recovery of Spermatogenesis in Irradiated Rats by Different Androgens
Endocrinology, September 1, 2002; 143(9): 3385 - 3396.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Schnorr, M. J. Bray, and J. D. Veldhuis
Aromatization Mediates Testosterone's Short-Term Feedback Restraint of 24-Hour Endogenously Driven and Acute Exogenous Gonadotropin-Releasing Hormone-Stimulated Luteinizing Hormone and Follicle-Stimulating Hormone Secretion in Young Men
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2600 - 2606.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. J. Olsen, G. Olson, S. M. Viselli, X. Gu, and W. J. Kovacs
Androgen Receptors in Thymic Epithelium Modulate Thymus Size and Thymocyte Development
Endocrinology, March 1, 2001; 142(3): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
W. Savino and M. Dardenne
Neuroendocrine Control of Thymus Physiology
Endocr. Rev., August 1, 2000; 21(4): 412 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Staples, T. A. Gasiewicz, N. C. Fiore, D. B. Lubahn, K. S. Korach, and A. E. Silverstone
Estrogen Receptor {alpha} Is Necessary in Thymic Development and Estradiol-Induced Thymic Alterations
J. Immunol., October 15, 1999; 163(8): 4168 - 4174.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. J. Olsen, S. M. Viselli, J. Fan, and W. J. Kovacs
Androgens Accelerate Thymocyte Apoptosis
Endocrinology, February 1, 1998; 139(2): 748 - 752.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L.-X. Shan, C. W. Bardin, and M. P. Hardy
Immunohistochemical Analysis of Androgen Effects on Androgen Receptor Expression in Developing Leydig and Sertoli Cells
Endocrinology, March 1, 1997; 138(3): 1259 - 1266.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Revskoy, I. Halasz, and E. Redei
Corticotropin-Releasing Hormone and Proopiomelanocortin Gene Expression Is Altered Selectively in the Male Rat Fetal Thymus by Maternal Alcohol Consumption
Endocrinology, January 1, 1997; 138(1): 389 - 396.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society